255 related articles for article (PubMed ID: 26245637)
1. First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient.
Dorjee K; Dierberg KL; Sadutshang TD; Reingold AL
BMC Res Notes; 2015 Aug; 8():337. PubMed ID: 26245637
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
[TBL] [Abstract][Full Text] [Related]
3. Cerebral tuberculosis in a patient with systemic lupus erythematosus following cyclophosphamide treatment: a case report.
Cooray S; Zhang H; Breen R; Carr-White G; Howard R; Cuadrado M; D'Cruz D; Sanna G
Lupus; 2018 Apr; 27(4):670-675. PubMed ID: 28764615
[TBL] [Abstract][Full Text] [Related]
4. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
6. Management of multi-drug resistant tuberculosis: practitioner's view point.
Prasad R
Indian J Tuberc; 2007 Jan; 54(1):3-11. PubMed ID: 17455417
[TBL] [Abstract][Full Text] [Related]
7. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.
Post FA; Grint D; Werlinrud AM; Panteleev A; Riekstina V; Malashenkov EA; Skrahina A; Duiculescu D; Podlekareva D; Karpov I; Bondarenko V; Chentsova N; Lundgren J; Mocroft A; Kirk O; Miro JM;
J Infect; 2014 Mar; 68(3):259-63. PubMed ID: 24247067
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
9. Outcome of protein-losing gastroenteropathy in systemic lupus erythematosus treated with prednisolone and azathioprine.
Mok CC; Ying KY; Mak A; To CH; Szeto ML
Rheumatology (Oxford); 2006 Apr; 45(4):425-9. PubMed ID: 16234272
[TBL] [Abstract][Full Text] [Related]
10. Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus.
Palavutitotai N; Buppajarntham T; Katchamart W
J Clin Rheumatol; 2014 Dec; 20(8):418-21. PubMed ID: 25417677
[TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with intravenous immunoglobulins in a patient affected by dermatomyositis/systemic lupus erythematosus overlap syndrome and tuberculosis.
Luzi G; Diamanti AP; Germano V; Laganà B; Di Rosa R; Salemi S; Stoppacciaro A; D'Amelio R
Clin Immunol; 2007 Nov; 125(2):127-30. PubMed ID: 17720626
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
14. Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
Roberts-Witteveen A; Reinten T; Christensen A; Sintchenko V; Seale P; Lowbridge C
Int J Tuberc Lung Dis; 2015 Jul; 19(7):850-6. PubMed ID: 26056113
[TBL] [Abstract][Full Text] [Related]
15. [Multidrug resistant tuberculosis in Iceland--case series and review of the literature].
Asgeirsson H; Blöndal K; Blöndal T; Gottfredsson M
Laeknabladid; 2009; 95(7-8):499-507. PubMed ID: 19553708
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
Fanouriakis A; Mastorodemos V; Pamfil C; Papadaki E; Sidiropoulos P; Plaitakis A; Amoiridis G; Bertsias G; Boumpas DT
Semin Arthritis Rheum; 2014 Jun; 43(6):751-8. PubMed ID: 24332007
[TBL] [Abstract][Full Text] [Related]
17. Could pulmonary arterial hypertension be an active index of systemic lupus erythematosus? A successful case of SLE-PAH cured by methylprednisolone pulse therapy.
Huang C; Zhang S; Tian Z; Li M; Zeng X
Lupus; 2014 Dec; 23(14):1533-6. PubMed ID: 25260565
[TBL] [Abstract][Full Text] [Related]
18. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran.
Mirsaeidi SM; Tabarsi P; Khoshnood K; Pooramiri MV; Rowhani-Rahbar A; Mansoori SD; Masjedi H; Zahirifard S; Mohammadi F; Farnia P; Masjedi MR; Velayati AA
Int J Infect Dis; 2005 Nov; 9(6):317-22. PubMed ID: 16183321
[TBL] [Abstract][Full Text] [Related]
19. The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy.
Oud KT; Bresser P; ten Berge RJ; Jonkers RE
Lupus; 2005; 14(12):959-63. PubMed ID: 16425576
[TBL] [Abstract][Full Text] [Related]
20. Cost of multi drug resistance tuberculosis in Germany.
Diel R; Nienhaus A; Lampenius N; Rüsch-Gerdes S; Richter E
Respir Med; 2014 Nov; 108(11):1677-87. PubMed ID: 25443398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
